{
  "ptid_time": "136_S_4189_2011-09-16",
  "img_path": "/data/qiuhui/data/adni/images/136_S_4189/2011-09-16/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 45,561 mm³, 62.3% above the reference mean. With a Z-score of 1.43 (92.3th percentile), this represents mild enlargement; hippocampal volume measures 5,960 mm³, 16.2% below the reference mean. With a Z-score of -1.49 (6.8th percentile), this represents mild atrophy; whole brain volume measures 1,025,430 mm³, 5.2% above the reference mean. With a Z-score of 0.66 (74.4th percentile), this represents normal volume ; entorhinal cortex volume measures 1,898 mm³, 48.3% below the reference mean. With a Z-score of -2.97 (0.2th percentile), this represents significant atrophy; fusiform gyrus volume measures 11,977 mm³, 29.6% below the reference mean. With a Z-score of -2.69 (0.4th percentile), this represents significant atrophy; middle temporal gyrus volume measures 15,806 mm³, 17.5% below the reference mean. With a Z-score of -1.52 (6.4th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 73.1 years. Gender is Female. Education: 15 years. MMSE: 28.0. MoCA: 21.0. Logical Memory: 4.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.30 SUVR (moderate elevated); Amyloid beta: 545.20 pg/mL (mild reduced); Total tau: 462.10 pg/mL (significant elevated); Phosphorylated tau: 33.90 pg/mL (moderate elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in the entorhinal cortex and fusiform gyrus, along with moderate atrophy in the middle temporal gyrus and mild hippocampal atrophy—all regions heavily implicated in Alzheimer’s disease (AD). Elevated biomarkers (Aβ reduction, elevated T-tau/P-tau, and AV45 positivity) strongly support AD pathology. Despite a near-normal MMSE, the MoCA score of 21 suggests subtle cognitive impairment, consistent with early-stage AD.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI) due to Alzheimer’s disease** (likely prodromal AD given biomarker profile).  \n\n**Confidence:** **High** (imaging and biomarkers align with AD continuum; MoCA deficit reinforces clinical relevance despite preserved MMSE).  \n\n*(Note: If longitudinal decline is documented, progression to dementia would be expected, but current cognitive performance—particularly MMSE—does not yet meet dementia thresholds.)*",
  "timestamp": "2025-07-26T16:06:01.740767"
}